跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bifidobacterium breve
首页
药物
Bifidobacterium breve
Experimental
Biotech
Bifidobacterium breve
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
UNII ID
L07O8T40TE
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SYNBIOTICS COMBINATION FOR BRAIN IMPROVEMENT
EP 3936134 C0
申请人: NUTRICIA NV
优先权: 2012
CN
EP
US
WO
8 件公开
Cognitive Function Improving Agent, Cognitive Function Maintaining Agent, Hippocampus Function Improving Agent, and Hippocampus Function Maintaining Agent
US 2023218686 A1
申请人: MORINAGA MILK INDUSTRY CO LTD
优先权: 2020
CN
EP
US
WO
6 件公开
BIFIDOBACTERIUM BREVE 207-1 AND USE THEREOF
EP 4012019 C0
申请人: BYHEALTH CO LTD
优先权: 2020
CN
EP
US
WO
6 件公开
Nutrition with non-viable Bifidobacterium and non-digestible oligosaccharide
US 9456629 B2
申请人: HOUGEE SANDER
优先权: 2007
CN
US
5 件公开
COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI PBS072 AND BIFIDOBACTERIUM BREVE BB077 OR BIFIDOBACTERIUM LACTIS BL050 AND THERAPEUTIC USES THEREOF
EP 4262834 B1
申请人: SYNBALANCE SRL
优先权: 2020
CN
EP
US
WO
4 件公开
BIFIDOBACTERIUM BREVE, COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE OR CULTURE THEREOF, AND USE OF BIFIDOBACTERIUM BREVE OR CULTURE THEREOF
EP 4653522 A1
申请人: TCI CO LTD
优先权: 2023
CN
EP
US
WO
4 件公开
Brain function improving agent
US 10980849 B2
申请人: MORINAGA MILK INDUSTRY CO LTD
优先权: 2016
CN
EP
US
4 件公开
Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof
US 2023346856 A1
申请人: UNIV JIANGNAN
优先权: 2020
CN
US
WO
4 件公开
Bioconversion of milk with Bifidobacterium breve for treatment of allergic manifestions in infants
US 9707258 B2
申请人: AUBERT-JACQUIN CÉCILE
优先权: 2007
CN
US
4 件公开
Bifidobacterium for dust mite allergy
US 9119414 B2
申请人: KNOL JAN
优先权: 2007
CN
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈